Risk factor analysis for survival and graft versus host disease in patients with chronic myelogenous leukemia submitted to allogeneic bone marrow transplantation.

被引：0
|
作者：
Moreira, VA [1 ]
Oliveira, FAM [1 ]
Pasquini, R [1 ]
de Medeiros, CR [1 ]
机构：
[1] Univ Fed Parana, Bone Marrow Transplantat Serv, BR-80060000 Curitiba, Parana, Brazil
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4950
引用
收藏
页码：385B / 385B
页数：1
相关论文
共 50 条
  • [11] Effect of Ly49A transfected lymphocytes on graft versus host disease and graft versus leukemia effect after allogeneic bone marrow transplantation.
    李玉华
    ChinaMedicalAbstracts, 2003, (02) : 137 - 138
  • [12] Usefulness of ursodeoxycholic: Acid for acute hepatic graft versus host disease in allogeneic bone marrow transplantation.
    Iwata, N
    Kanamaru, A
    Nakamura, Y
    Seto, Y
    Kakishita, E
    HEPATOLOGY, 1996, 24 (04) : 983 - 983
  • [13] DISTINCT PATTERNS OF MINIMAL RESIDUAL DISEASE-ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    PICHERT, G
    ROY, DC
    GONIN, R
    ALYEA, EP
    BELANGER, R
    GYGER, M
    PERREAULT, C
    BONNY, Y
    LERRA, I
    MURRAY, C
    SOIFFER, RJ
    RITZ, J
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1704 - 1713
  • [14] Photopheresis as a treatment for chronic graft-vs-host disease after allogeneic bone marrow transplantation.
    DiVenuti, G
    Miller, K
    Sprague, K
    Grodman, H
    Foss, F
    BLOOD, 2002, 100 (11) : 846A - 846A
  • [15] Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia
    Gale, RP
    Hehlmann, R
    Zhang, MJ
    Hasford, J
    Goldman, JM
    Heimpel, H
    Hochhaus, A
    Klein, JP
    Kolb, HJ
    McGlave, PB
    Passweg, JR
    Rowlings, PA
    Sobocinski, KA
    Horowitz, MM
    BLOOD, 1998, 91 (05) : 1810 - 1819
  • [16] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (24): : 3208 - 3211
  • [17] Allogeneic bone marrow transplantation in children with chronic myelogenous leukemia
    Sharathkumar, A
    Thornley, I
    Saunders, EF
    Calderwood, S
    Freedman, MH
    Doyle, J
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (03) : 215 - 219
  • [18] Improved survival of patients with chronic myelogenous leukemia (CML) undergoing allogeneic bone marrow transplantation (BMT).
    Moreb, J
    Johnson, T
    Kubilis, P
    Myers, L
    BLOOD, 1995, 86 (10) : 3826 - 3826
  • [19] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    SPECK, B
    BORTIN, MM
    CHAMPLIN, R
    GOLDMAN, JM
    HERZIG, RH
    MCGLAVE, PB
    MESSNER, HA
    WEINER, RS
    RIMM, AA
    LANCET, 1984, 1 (8378): : 665 - 668
  • [20] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML)
    CHAMPLIN, R
    GALE, RP
    EXPERIMENTAL HEMATOLOGY, 1982, 10 : 19 - 19
12345